Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Pleuropulmonary Blastoma Registry, |
RCV000240901 | SCV000195640 | pathogenic | DICER1-related tumor predisposition | 2014-11-11 | criteria provided, single submitter | clinical testing | |
Foulkes Cancer Genetics LDI, |
RCV000240901 | SCV001371962 | pathogenic | DICER1-related tumor predisposition | 2019-07-01 | criteria provided, single submitter | curation | ACMG criteria met: PVS1, PM2, PP4 |
Victorian Clinical Genetics Services, |
RCV000240901 | SCV005880288 | pathogenic | DICER1-related tumor predisposition | 2024-11-28 | criteria provided, single submitter | clinical testing | Evidence in support of pathogenic classification: - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). - Variant is absent from gnomAD (v2, v3 and v4). - This variant has limited previous evidence of pathogenicity in unrelated individuals. It has been reported in the literature as heterozygous in an individual with granulosa cell tumour (PMID: 38898688). - Other NMD-predicted variant(s) comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). Additional information: - This variant is heterozygous. - This gene is associated with autosomal dominant disease. - No published segregation evidence has been identified for this variant. - No published functional evidence has been identified for this variant. - Loss of function is a known mechanism of disease in this gene and is associated with DICER1-related conditions. - Inheritance information for this variant is not currently available in this individual. |
Department of Pathology and Laboratory Medicine, |
RCV000240901 | SCV005912872 | likely pathogenic | DICER1-related tumor predisposition | 2024-11-19 | criteria provided, single submitter | clinical testing |